FDA Reopens Pre-Submissions For Non-COVID-19 Products
Executive Summary
The US agency now has the staff it needs to review pre-submissions for devices that aren’t related to the pandemic, says a new blog post from device center director Jeff Shuren and Office of Product Evaluation and Quality director William Maisel.
You may also be interested in...
EUA Draft Guidance: FDA Wants ‘Transition Implementation Plan’ Along With Marketing Submission
In a long-awaited draft guidance document, the US agency lays bare its thinking on how companies can best ensure that their products granted emergency use authorization status can still be sold post-pandemic (or not).
For Second Time This Month, Medtronic Announces Class I FDA Recall Related To HeartWare System Component
Medtronic, Baxter and BD are all facing recalls, with Medtronic finding yet another issue with HeartWare HVAD systems. Separately, the FDA put a Baxter respiratory device recall into Class I, and BD announced a recall on intraosseous devices.
FDA Plans Meeting On Pulse Oximeter Accuracy
US regulators plan to hold a public meeting later this year to address concerns the devices are less accurate for people with darker skin tones.